NCT06845488 Application of Virtual Reality Technology to Treatment of Social Anxiety
| NCT ID | NCT06845488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-11-07 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-11-07 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social anxiety in adults with autism and social anxiety (SA), to identify characteristics associated with benefitting from the CBT-VR treatment and to assess acceptability and feasibility of the VR intervention for patients receiving it and use findings to improve methods and to prepare for a community based pragmatic trial.
Eligibility Criteria
Inclusion Criteria: * Autism Spectrum Disorder (ASD) (diagnosed by a qualified professional) * verbal and literate in English or Spanish * average or greater intellectual ability, based on history and interview * able to operate a computer (Windows or Mac). Exclusion Criteria: * current or historical severe mental illness such as schizophrenia, bipolar disorder, or severe depression * intellectual disability or a learning disability that would interfere with participating (e.g., unable to read) * unable use the technology or do not have access to the technology * unable to read
Contact & Investigator
Katherine Loveland, PhD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center at Houstom
Frequently Asked Questions
Who can join the NCT06845488 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06845488 currently recruiting?
Yes, NCT06845488 is actively recruiting participants. Contact the research team at Katherine.A.Loveland@uth.tmc.edu for enrollment information.
Where is the NCT06845488 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06845488 clinical trial?
NCT06845488 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Katherine Loveland, PhD at The University of Texas Health Science Center at Houstom. The trial plans to enroll 40 participants.